id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2019-E-3017-0003,FDA,FDA-2019-E-3017,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2020-03-03T05:00:00Z,2020,3,2020-03-03T05:00:00Z,,2020-03-03T13:35:48Z,,0,0,09000064843d8922